Followers | 116 |
Posts | 11877 |
Boards Moderated | 1 |
Alias Born | 03/08/2004 |
Wednesday, June 28, 2017 5:00:27 PM
https://www.linkedin.com/in/taylor-richards-21847b47
SIML
http://ih.advfn.com/p.php?pid=nmona&article=75133653&symbol=SIML
Investment Analyst
Greater New York City Area
Financial Services
Current
Tri-Bridge Ventures, LLC, LIVINGSTON COLLISION INC
Previous
Various Stores, Livingston Lacrosse Club
Education
Syracuse University
Experience
Investment Analyst
Tri-Bridge Ventures, LLC
June 2017 – Present (1 month)Greater New York City Area
Tri-Bridge Ventures, LLC is a New York based Institutional Investor that focuses on transactions with publicly traded companies on the OTC and lower tier NASDAQ Exchanges. The firm sources, structures and executes on investments in companies with market capitalization primarily under $250 million. The Tri-Bridge Ventures team has the experience and understanding of the public markets to identify investment opportunities as well as the ability to structure both equity and debt transactions. As a boutique private investment fund, we can tailor bespoke investments to the needs of each company and allocate funding in a very timely manner.
Operations and Finance Intern
LIVINGSTON COLLISION INC
September 2011 – Present (5 years 10 months)
Posted sales transactions, and dealt with bank account reconciliations.
Worked with QuickBooks.
Office work including answering sales calls, and managed customers insurance claims.
Sales Associate
Various Stores
January 2012 – August 2015 (3 years 8 months)
Throughout high school I worked in various stores including retail and food services. In August 2015 I started my freshman year at Syracuse University.
Instructor
Livingston Lacrosse Club
March 2010 – May 2015 (5 years 3 months)
#1). You have money. Other people want it. All of it!
#2). You want easy money. So does everybody else. They'll get it, too....yours! (and all of it!)
#3). You tell yourself you're smart. You won't lose your money. Fact: Other people are smarter,
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM